Statements & Press Releases

Mar 16, 2023

CALIFORNIA COURT OF APPEALS UPHOLDS LOWER COURT RULING CALLING OPTUMRX’S FORCED ARBITRATION CONTRACT CLAUSE “UNCONSCIONABLE”

Decision Affirms Lower Court Ruling, Opens the Door for Independent Pharmacies to Publicly Hold OptumRx Accountable for Wrongdoings

Mar 7, 2023

PUTT to Governor DeSantis: Thank You for Having the Guts to Take On Pharmacy Benefit Middlemen, Change Status Quo for Floridians

Governor DeSantis’ Bold Leadership is an Example to Other States Seeking to Stop PBMs from Profiteering Off Consumers, Employers and Taxpayers

Feb 23, 2023

PUTT Statement on Commissioner Christine Wilson’s FTC Departure

Jan 9, 2023

PUTT Comment to the FTC RE: Unfair or Deceptive Fees Trade Regulation Rule Commission Matter No. R207011

Jul 8, 2022

PUTT: GOVERNOR DESANTIS’ BOLD STAND FOR DRUG PRICE TRANSPARENCY PROVES STATES CAN AND SHOULD LEAD THE WAY ON PBM REFORM

Jun 17, 2022

PUTT APPLAUDS FTC VOTE TO LAUNCH PBM STUDY AND FTC FOR ISSUING ENFORCEMENT POLICY STATEMENT FOLLOWING INSULIN HEARING

Jun 8, 2022

FTC Launches 6(b) Study of PBMs, Votes to Order the 6 Largest PBMs to Turn Over Documents and Data as Part of Study

Apr 20, 2022

Millions Overpaid for Prescriptions in Secretive Scheme, Lawsuit Filed by Attorney General Jeff Landry to Recover Inflated Charges

Apr 20, 2022

PUTT Sign-On Letter to the FTC Regarding PBM Practices and Their Harm to the Healthcare System

Mar 7, 2022

PUTT Statement to CMS Regarding the Medicare DIR Fee Proposed Rule Change

RE: Medicare Program; Contract Year 2023 Policy and Technical Changes to the Medicare
Advantage and Medicare Prescription Drug Benefit Programs (CMS-4192-P)

Feb 18, 2022

PUTT STATEMENT ON THE FAILURE OF THE FTC TO AUTHORIZE STUDY OF PBM-PHARMACY RELATIONSHIP FOLLOWING IMPASSIONED PUBLIC HEARING

Commissioners Wilson and Phillips: Your Actions Lead Us to Wonder if You Participated in the Hearing with an Open Mind, or if You are Protecting the Rights of Modern-Day Robber Barons

Dec 31, 2021